CLINICAL_TRIALS
trial_result
· 2008-03-05
Clinical Trial Update: Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) [Phase 4]
Summary
Phase 4 clinical trial update for ONTAK (denileukin diftitox) in Cutaneous T-Cell Lymphoma; the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Lymphoma, T-Cell, Cutaneous | Phase 4 | Status: COMPLETED